发明授权
US09080170B2 Modified U7 snRNAs for treatment of neuromuscular diseases 有权
修饰的U7 snRNA用于治疗神经肌肉疾病

Modified U7 snRNAs for treatment of neuromuscular diseases
摘要:
The present invention relates to a method to improve the activity of engineered U7 snRNAs used in the context of RNA-based therapeutics; particularly in exon skipping, exon inclusion, and mRNA eradication strategies. The resulting modified U7 snRNAs are useful for treating neuromuscular diseases, in particular Duchenne neuromuscular dystrophy, myotonic dystrophy DM1 and spinal muscular atrophy.
信息查询
0/0